Aurobindo Pharma USA, Inc. has issued a voluntary recall of three of its sartan-based prescription medications after discovering trace amounts of a carcinogenic substance known as N-nitrosodiethylamine (NDEA). The recall, which the FDA announced on Dec. 31st, affects a total of 80 lots of Valsartan, Amlodipine Valsartan, and Valsartan HCTZ pills with expiration dates between May 2019 and March 2021.
This week, Illinois Attorney General Lisa Madigan reported that more than 500 cases of child sexual abuse were swept under the rug by the six Roman Catholic dioceses across the state. Earlier, the Church reported 185 members of the clergy who had “credible allegations” leveled against them. However, according to AG Madigan's report, the real number is 690.
With all eyes on Pennsylvania and the shocking grand jury report that was released earlier this fall, it is easy to forget that cases of pedophile priests in the Roman Catholic Church is a worldwide scandal.
One of the challenges when it comes to determining damages in injury lawsuits is putting a monetary value on intangible losses, such as pain and suffering, emotional distress, and anxiety. These are considered to be “non-economic damages,” and fall under the category of “mental anguish.” Putting a dollar figure on emotional pain is difficult, but it is nonetheless a factor that can diminish the quality of life as surely as a crippling injury.
After two years of clinical trials, a new type of IVC filter was recently implanted in a number of patients under “real world” conditions in an Arizona hospital. The product is called the “Sentry” and is produced by BTG Interventional Medicine, a company based in the UK.
Introduced this month at Vascular Interventional Advances Conference in Las Vegas, the new IVC filter has what the manufacturer describes as a “unique bioconversion feature”, making retrieval of the device unnecessary.
Environmental activist groups in Canada have accused the country's health ministry, Health Canada, of being secretly influenced by Monsanto when it renewed its approval of the chemical glyphosate, the primary ingredient in the company's flagship product, RoundupTM.
For the second time in as many weeks, the Food and Drug Administration has notified physicians and patients that yet another sartan drug used to treat hypertension has been contaminated with a carcinogenic industrial chemical. The manufacturer of the drug has issued a voluntary recall for a single lot of the medication losartan (potassium hydrochlorothiazide), identified as JB8912.
Australian researchers recently published a study that has found a link between the use of proton pump inhibitors (PPIs) and iron deficiency. When iron levels in the body are insufficient, it can lead to anemia, a condition in which the amount of hemoglobin (red blood cells) decline to dangerously low levels. Untreated, anemia puts excess strain on the heart muscle, causing a lack of oxygen and leading to serious organ damage. In extreme cases, it can be fatal.
Levin Papantonio Thomas Mitchell Rafferty & Proctor P.A. of Pensacola, Florida, one of the nation’s preeminent Plaintiffs law firms, announced today that it has won a verdict along with John F. Nevares & Associates of Santurce, Puerto Rico, in a FINRA Arbitration against UBS Financial Services Inc. (UBS) and UBS Financial Services Inc. of Puerto Rico (UBS-PR). The verdict, for total damages in excess of $19 million, was obtained on behalf of their client in FINRA Arbitration # 15-01833.
In a recent decision by a Florida federal judge, Abilify maker Otsuka Pharmaceuticals was absolved of responsibility to preserve company e-mails that might have served as evidence for plaintiffs in current Abilify litigation. The reason: the emails were written years ago, long before the company could reasonably have anticipated having to defend itself against lawsuits.
Cook Medical, already facing more than 3,000 lawsuits over defective IVC filters, was targeted in several more complaints filed this month by injured parties from California to New York. The lawsuits name two different models: the Günther Tulip® and the Celect®. At the same time, Rex Medical L.P. and Argon Medical Devices Inc. have been targeted by plaintiffs in Michigan and New Jersey over their OptionTM ELITE IVC Filter. In both of the latter cases, the device tilted, puncturing the artery wall, and surgeons were unable to remove them.
U.K. Health Secretary Announces Temporary Ban on Pelvic Mesh Repairs – But Use of Hernia Mesh Continues
Last month, the death of a 75-year-old woman in Loanhead, Scotland, was officially attributed to the surgical mesh that had been used to repair her pelvic organ prolapse (PoP). It is the first time that surgical mesh has been listed on an official death certificate as an “underlying cause.”
After several years of flying under the radar, gadolinium injury litigation is once again coming to public attention. Part of the reason has to do with film actor Chuck Norris and his wife Gena. The couple filed a lawsuit in November 2017 against three manufacturers of gadolinium-based contrast agents (GBCA) after Gena Norris became seriously ill following a routine MRI scan, during which she was inj
Only a few months ago, government health authorities in Europe and the U.S. issued recalls for the blood pressure medication valsartan over concerns of the presence of a carcinogenic industrial chemical known as N-nitrosodimethylamine (NDMA).
Gadolinium is a “rare earth” metal or a lanthanide. It is used in superconductors, catalytic converters, lasers, and high-flux magnets. The properties of gadolinium have made it especially useful in medical imaging technology.
Gadolinium essentially “calms” the hydrogen atoms contained in the water of bodily tissues. Otherwise, hydrogen atoms are magnetized by the radiation used in X-rays and MRIs, making it difficult to obtain a clear image.
Some victims of Nephrogenic System Fibrosis due to gadolinium toxicity are turning to chelation in hopes of ridding their bodies of the toxic heavy metal. Among them: Gena Norris, wife of popular film star Chuck Norris, who filed a lawsuit in California last year against three manufacturers of gadolinium-based contrasting agents (GABAs).
A grand jury in Pennsylvania has issued an extensive report on sexual abuse in the Roman Catholic Church. The 887 page-long report is the culmination of an 18-month long investigation, identifying over 1,000 victims and more than 300 perpetrators in six dioceses in Pennsylvania. The report includes correspondence as well as the names and detailed histories of clergy who have been accused of molesting c